ArticleJournal of cancer research and clinical oncology2024
AR expression-independent XRCC3 mediates DNA damage-induced p53/Bax signaling pathway activation against prostate cancer.
Hailong Xie et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.